Effects of marine in the treatment of chronic hepatitis B patients with low viral load
-
摘要: 目的观察序贯应用苦参素胶囊和苦参素注射液治疗低病毒载量慢性乙型肝炎的疗效。方法选择60例低病毒载量慢性乙型肝炎患者,随机分为对照组和治疗组各30例,对照组给予常规保肝治疗,治疗组同时序贯应用苦参素胶囊和苦参素注射液治疗,总疗程24周,观察两组治疗4、12、24周时的ALT、HBV DNA转阴率及HBeAg/抗-HBe血清转换率。结果治疗组在改善肝功能、HBV DNA转阴率及HBeAg/抗-HBe血清转换率方面优于对照组。结论序贯应用苦参素胶囊和苦参素注射液治疗低病毒载量慢性乙型肝炎患者可以获得较高的应答率。Abstract: Objective To observe the effects of Marine in chronic hepatitis B patients with low viral load.Methods Sixty patients with CHB were randomly divided into control group and treatment group.Patients in the control group received general liver protection therapy, while those in the treatment group received marine capsules and marine injection sequentially.The period of treatment was 24 weeks.The ALT, HBV DNA and HBeAg/HBeAb were checked 4 weeks, 12 weeks and 24 weeks after treatment.Results At the end of treatment the negative conversion rates of ALT and HBV DNA and HBeAg/HBeAb seroconversion rate were significantly higher in the treatment group than in the control group. Conclusion Marine capsules and marine injection sequentially in the treatment of chronic hepatitis B patients with low viral load can obtain higher rate of virological response and serological response.
-
Key words:
- marine /
- hepatitis B /
- chronic
-
[1]中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2010版) [J].临床肝胆病杂志, 2011, 27 (1) :Ⅰ-XVI. [2]梅晓莉.慢性乙型病毒性肝炎的治疗研究进展[J].临床和实验医学杂志, 2009, 8 (2) :131. [3]张春, 米忠友.慢性乙型肝炎现代综合治疗新进展[J].临床军医杂志, 2010, 38 (6) :1062-1064. [4]中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华内科杂志, 2001, 19 (1) :62-68. [5]张学武, 李旭, 胡国启, 等.氧化苦参碱治疗慢性乙型肝炎致转氨酶反跳的临床意义及其相关因素[J].临床肝胆病杂志, 2008, 24 (1) :14-17. [6]于晶, 孙跃先, 赵金满, 等.乙型肝炎病毒DNA复制状态与原发性肝癌的关系研究[J].中国全科医学, 2010, 13 (12C) :4072-4073. [7]郑卫东, 马晓军, 吴剑华, 等.苦参素注射液抗乙肝病毒疗效及与中医证型关系的临床研究[J].中西医结合肝病杂志, 2008, 18 (2) :77-79.
本文二维码
计量
- 文章访问数: 3389
- HTML全文浏览量: 13
- PDF下载量: 680
- 被引次数: 0